Results 251 to 260 of about 50,976 (267)

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Drug and Alcohol Dependence, 2020
Alison Marshall, Jason Grebely, Gregory Dore   +2 more
exaly  

DaaS Development

Wiehann Olivier, Pieter Buys
openaire   +1 more source

Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections

Diagnostics, 2023
exaly  

Access to DAA therapy, and the role of DAAs in targeted HCV elimination

Elena Vargas-Accarino, Rafael Esteban, María Buti   +2 more
openaire   +1 more source

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance

Hepatic Oncology, 2020
Claudio Tiribelli, Devis Pascut, Muhammad Yogi Pratama   +2 more
exaly  

DAA-VERANSTALTUNGSKALENDER 2015

Akupunktur & Aurikulomedizin, 2015
openaire   +1 more source

DAAs prevent HCC – the plot thickens

Digestive and Liver Disease, 2019
Markus Peck-Radosavljevic, Ashwani K. Singal   +1 more
openaire   +2 more sources

Novel action of 3,4‐DAA ameliorating acute liver allograft injury

Cell Biochemistry and Function, 2011
exaly  

Efficient Signatures of Knowledge and DAA in the Standard Model

Lecture Notes in Computer Science, 2013
Essam Ghadafi, Georg Fuchsbauer, David Bernhard   +2 more
exaly  

Multiplexer based two variables DAA

2014
T N Prabakar
exaly